Suppr超能文献

联合肝硬度和 Α-胎蛋白在持续病毒学应答后进一步预测慢性丙型肝炎患者的长期肝脏相关事件。

Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C.

机构信息

Department of Medicine, China Medical University, Taichung, Taiwan.

Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.

出版信息

Can J Gastroenterol Hepatol. 2022 Jul 4;2022:5201443. doi: 10.1155/2022/5201443. eCollection 2022.

Abstract

AIMS

Long-term risk stratification using combined liver stiffness (LS) and clinically relevant blood tests acquired at the baseline further beyond the sustained virologic response (SVR) visit for chronic hepatitis C (CHC) has not been thoroughly investigated. This study retrospectively investigated the prognostics of liver-related events (LREs) further beyond the SVR visit.

METHODS

Cox regression and random forest models identified the key factors, including longitudinal LS and noninvasive test results, that could predict LREs, including hepatocellular carcinoma, during prespecified follow-ups from 2010 to 2021. Kaplan-Meier survival analysis estimated the significance of between-group risk stratification.

RESULTS

Of the entire eligible cohort ( = 520) of CHC patients with SVR to antiviral therapy, 28 (5.4%) patients developed post-SVR LREs over a median follow-up period of 6.1 years (interquartile range = 3.5-8.7). The multivariate Cox regression analysis identified two significant predictors of LREs after the year 3 post-SVR (Y3PSVR) baseline (LRE,  = 15 of 28, 53.6%, median follow-up = 4.1 [1.6-6.4] years after Y3PSVR): LS at Y3PSVR (adjusted hazard ratio [aHR] = 3.980, 95% confidence interval [CI] = 2.085-7.597, < 0.001), and -fetoprotein (AFP) at Y3PSVR (aHR = 1.017, 95% CI = 1.001-1.034, =0.034). LS ≥1.45 m/s and AFP ≥3.00 ng/mL for Y3PSVR yielded positive likelihood ratios of 4.24 and 2.62, respectively. Kaplan-Meier analysis revealed that among the stratified subgroups, the subgroup with concurrent LS ≥1.45 m/s and AFP ≥3.00 ng/mL at Y3PSVR exhibited the highest risk of LREs after Y3PSVR (log-rank < 0.001).

CONCLUSION

We recommend the combined use of concurrent LS and AFP in future prediction models for LREs in CHC. Patients with concurrently high LS and AFP values further beyond the SVR visit may require a recall policy involving intense surveillance.

摘要

目的

对于慢性丙型肝炎(CHC)患者,在获得持续病毒学应答(SVR)后,使用联合肝脏硬度(LS)和临床相关血液检测进行长期风险分层,这种方法在 SVR 就诊之外的进一步研究中尚未得到充分探讨。本研究回顾性调查了 SVR 就诊之外的肝脏相关事件(LREs)的预后情况。

方法

Cox 回归和随机森林模型确定了关键因素,包括纵向 LS 和非侵入性检测结果,这些因素可以预测 2010 年至 2021 年期间指定随访期间的 LREs,包括肝细胞癌。Kaplan-Meier 生存分析估计了组间风险分层的意义。

结果

在抗病毒治疗后获得 SVR 的整个合格 CHC 患者队列( = 520)中,有 28 名(5.4%)患者在中位随访 6.1 年(四分位距 = 3.5-8.7)后发生 SVR 后 LREs。多变量 Cox 回归分析确定了 SVR 后 3 年(Y3PSVR)基线后 LREs 的两个显著预测因素(LRE, = 28 例中的 15 例,53.6%,中位随访 = Y3PSVR 后 4.1 [1.6-6.4] 年):Y3PSVR 时的 LS(调整后的危险比[aHR] = 3.980,95%置信区间[CI] = 2.085-7.597,<0.001)和 Y3PSVR 时的甲胎蛋白(AFP)(aHR = 1.017,95%CI = 1.001-1.034,=0.034)。Y3PSVR 时 LS≥1.45 m/s 和 AFP≥3.00 ng/mL 的阳性似然比分别为 4.24 和 2.62。Kaplan-Meier 分析显示,在分层亚组中,Y3PSVR 时同时存在 LS≥1.45 m/s 和 AFP≥3.00 ng/mL 的亚组在 Y3PSVR 后 LREs 的风险最高(对数秩检验 < 0.001)。

结论

我们建议在未来的 CHC 肝脏相关事件预测模型中联合使用 LS 和 AFP。在 SVR 就诊之外同时存在高 LS 和 AFP 值的患者可能需要召回政策,包括强化监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4605/9273470/ae75a981b988/CJGH2022-5201443.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验